Ativan and Calquence drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ativan (lorazepam) and Calquence (acalabrutinib). Common drug interactions include death among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Ativan and Calquence. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Ativan?

Ativan has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 78,506 Ativan users. Check the latest studies of Ativan.

What is Calquence?

Calquence has active ingredients of acalabrutinib. eHealthMe is studying from 5,627 Calquence users. Check the latest studies of Calquence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

19 people who take Ativan and Calquence together, and have interactions are studied.

Ativan and Calquence drug interactions.

What are the common drug interactions of Ativan and Calquence, by gender? *:

female:

  1. Death
  2. Dizziness
  3. Arrhythmia (irregular heartbeat)
  4. Blood chloride increased
  5. Blood glucose increased
  6. Cardiac disorder
  7. Cardiac failure congestive
  8. Decreased activity
  9. Mitral valve incompetence (inefficient heart valve)
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

male:

  1. Death
  2. Abdominal pain
  3. Richter's syndrome (hairy cell cancer changes in fast growing b cell cancer tumour)
  4. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  5. Acute respiratory distress syndrome
  6. Acute respiratory failure
  7. Asthma
  8. Cytokine storm (over-protective immune response that can actually be fatal)
  9. Glomerular filtration rate decreased
  10. Prostate cancer

What are the common drug interactions of Ativan and Calquence, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Death

60+:

  1. Cardiac disorder
  2. Death
  3. Cardiac failure congestive
  4. Cytokine storm (over-protective immune response that can actually be fatal)
  5. Decreased activity
  6. Glomerular filtration rate decreased
  7. Mitral valve incompetence (inefficient heart valve)
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Prostate cancer
  10. Pulmonary valve incompetence

What are the existing conditions these people have? *

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 10 people, 52.63%
  2. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 15.79%
  3. Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 10.53%
  4. Secretion Discharge: 1 person, 5.26%
  5. Panic Disorder: 1 person, 5.26%
  6. Pain: 1 person, 5.26%
  7. High Blood Cholesterol: 1 person, 5.26%
  8. Diabetes: 1 person, 5.26%
  9. B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 1 person, 5.26%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ativan and Calquence?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ativan and Calquence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ativan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Calquence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ativan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calquence and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and acalabrutinib (the active ingredients of Ativan and Calquence, respectively), and Ativan and Calquence (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: